More than 10 clinical studies
Gondola Medical Technologies is committed to producing unbiased scientific evidence on the effectiveness of Gondola AMPS therapy. The safety and efficacy of the therapy has been documented in clinical research studies of over 250 Parkinson’s disease patients. The studies indicated that with regular use increased walking speed, faster timed up-and-go (TUG), increased stride length, more symmetrical gait, and improved turning capabilities, signifying improvements in dynamic balance could be observed.
Research on Gondola AMPS therapy is still ongoing, as scientists and clinicians continue to explore its full potential for patients with Parkinson’s disease and other neurological conditions. This ongoing research aims to gain a deeper understanding of the therapy’s long-term effects, optimize treatment protocols, and uncover additional applications.
As new findings emerge, the knowledge and insights gained will contribute to refining and enhancing Gondola AMPS therapy, ensuring it remains a cutting-edge and effective treatment option for those in need.
If you would like to collaborate with us, please don’t hesitate to get in touch.